問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Rehabilitation Medicine

更新時間:2023-09-19

陳靖倫
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2019-06-01 - 2021-04-12

Phase III

An Asian, Multicenter, Randomized, Double-blind, Placebo-controlled, 14-week Study of Mirogabalin in Participants With Central Neuropathic Pain Followed by a 52-week, Open-label Extension
  • Condition/Disease

    Central Neuropathic Pain

  • Test Drug

    DS-5565 (Mirogabalin)

Participate Sites
4Sites

Terminated4Sites